The US-China biotech trade war that isn’t

On October 22, the US Treasury proposed adding biotechnology to the list of Chinese sectors that American capital may no longer finance. A week earlier, China’s Ministry of Commerce had proposed barring the foreign sale of five biomedical technologies, including cell and gene therapy platforms. Two governments that …

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.